184 related articles for article (PubMed ID: 8454355)
1. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model.
Barton BE; Jackson JV
Infect Immun; 1993 Apr; 61(4):1496-9. PubMed ID: 8454355
[TBL] [Abstract][Full Text] [Related]
2. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock.
Oku H; Nakazato H; Horikawa T; Tsuruta Y; Suzuki R
Eur J Pharmacol; 2002 Jun; 446(1-3):167-76. PubMed ID: 12098599
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.
Gallay P; Heumann D; Le Roy D; Barras C; Glauser MP
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7922-6. PubMed ID: 7520172
[TBL] [Abstract][Full Text] [Related]
5. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
Brouckaert P; Everaerdt B; Fiers W
Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
[TBL] [Abstract][Full Text] [Related]
6. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.
Miethke T; Wahl C; Heeg K; Echtenacher B; Krammer PH; Wagner H
J Exp Med; 1992 Jan; 175(1):91-8. PubMed ID: 1730929
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model.
Morikawa A; Sugiyama T; Kato Y; Koide N; Jiang GZ; Takahashi K; Tamada Y; Yokochi T
Infect Immun; 1996 Mar; 64(3):734-8. PubMed ID: 8641774
[TBL] [Abstract][Full Text] [Related]
8. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
Mignon A; Rouquet N; Fabre M; Martin S; Pagès JC; Dhainaut JF; Kahn A; Briand P; Joulin V
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1308-15. PubMed ID: 10194182
[TBL] [Abstract][Full Text] [Related]
9. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
Greeneltch KM; Haudenschild CC; Keegan AD; Shi Y
Brain Behav Immun; 2004 Sep; 18(5):476-84. PubMed ID: 15265541
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone.
Cain WC; Stuart RW; Lefkowitz DL; Starnes JD; Margolin S; Lefkowitz SS
Int J Immunopharmacol; 1998 Dec; 20(12):685-95. PubMed ID: 9877280
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-ethyl-1-phenyl-2-(1H) pyridone on serum biomarkers of multiorgan dysfunction and mortality in lipopolysaccharide/glactosamine and cecal ligation and puncture models of septic shock in mice.
Grattendick KJ; Nakashima JM; Giri SN
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):27-50. PubMed ID: 22032089
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice.
Freudenberg MA; Galanos C
Infect Immun; 1991 Jun; 59(6):2110-5. PubMed ID: 2037372
[TBL] [Abstract][Full Text] [Related]
13. An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality.
Bucklin SE; Silverstein R; Morrison DC
Infect Immun; 1993 Aug; 61(8):3184-9. PubMed ID: 8335348
[TBL] [Abstract][Full Text] [Related]
14. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production.
Zhang H; Peterson JW; Niesel DW; Klimpel GR
J Immunol; 1997 Nov; 159(10):4868-78. PubMed ID: 9366412
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock.
Li C; Gu H; Yu M; Yang P; Zhang M; Ba H; Yin Y; Wang J; Yin B; Zhou X; Li Z
Cell Death Dis; 2019 Aug; 10(8):586. PubMed ID: 31383857
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of constitutive type and inducible type heat shock proteins in response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model.
Morikawa A; Kato Y; Sugiyama T; Koide N; Kawai M; Fukada M; Yoshida T; Yokochi T
FEMS Immunol Med Microbiol; 1998 May; 21(1):37-45. PubMed ID: 9657319
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action.
Badger AM; Olivera D; Talmadge JE; Hanna N
Circ Shock; 1989 Jan; 27(1):51-61. PubMed ID: 2492908
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-ethyl-1-phenyl-2-(1H) pyridone on serum biomarkers of multiorgan dysfunction and mortality in lipopolysaccharide/galactosamine and cecal ligation and puncture models of septic shock in mice.
Grattendick KJ; Nakashima JM; Giri SN
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():27-50. PubMed ID: 25022029
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on endotoxic shock in mice.
Koyama Y; Motobu M; Hikosaka K; Yamada M; Nakamura K; Saido-Sakanaka H; Asaoka A; Yamakawa M; Sekikawa K; Kitani H; Shimura K; Nakai Y; Hirota Y
Int Immunopharmacol; 2006 Feb; 6(2):234-40. PubMed ID: 16399628
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.
Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF
Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
